Biểu đồ giá cổ phiếu OCS
OCS Cổ tức
Oculis Holding AG
$22.7
-23.42%
$-6.94
Khi đóng cửa: May 29, 16:00:00 GMT-4
$15
-33.89%
$-7.69
Phiên sau giờ: May 29, 20:00:00 GMT-4
Quay lại
Oculis Holding AG (OCS) Cổ tức
Thống kê chính
Giá đóng cửa trước
$29.65
Giá mở cửa
$29.3
Phạm vi ngày
$15 - $29.64
Phạm vi 52 tuần
$15 - $34.47
Khối lượng
1.5M
Khối lượng trung bình
357.6K
Tỷ suất cổ tức
--
EPS (TTM)
-1.92
Vốn hóa thị trường
$765.2M
OCS là gì?
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The company is headquartered in Zug, Zug and currently employs 60 full-time employees. The company went IPO on 2023-03-03. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
